An evidence-based resuscitation algorithm applied from the emergency room to the ICU improves survival of severe septic shock

Minerva Anestesiologica

Volumn 74, Issue 6, 2008, Pages 223-231

  Castro, R ^a   Regueira, T ^a   Aguirre, M L ^a   Llanos, O P ^a   Bruhn, A ^a   Bugedo, G ^a   Dougnac, A ^a   Castillo, L ^a   Andresen, M ^a   Hernández, Glenn ^a,b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b NONE   (Chile)

Author keywords

Algorithms; Epinephrine; Norepinephrine; Sepsis; Septic; Shock

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; DOBUTAMINE; DROTRECOGIN; HYDROCORTISONE; HYPERTENSIVE FACTOR; INFUSION FLUID; NORADRENALIN; STEROID; VASOACTIVE AGENT;

ACCURACY; ADULT; AGED; ALGORITHM; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG USE; EMERGENCY WARD; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RESUSCITATION; SEPTIC SHOCK; SURVIVAL TIME;

ALGORITHMS; EMERGENCY TREATMENT; EVIDENCE-BASED MEDICINE; HUMANS; INTENSIVE CARE UNITS; MIDDLE AGED; PROSPECTIVE STUDIES; SHOCK, SEPTIC; SURVIVAL RATE;

EID: 47849093761     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. ESICM, ISF, SCCM. An International Effort. Action Demanded On World's Oldest Killer. 2002; Available from http://www.survivingsepsis.org/ media_press_release.html:(last accessed 04/27/2006).
2. Action Demanded On World's Oldest Killer. Accessed available online at: http://www.survivingsepsis.org/media_press_release.html
3. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.
4. Vincent JL, Habib AM, Verdant C, Bruhn A. Sepsis diagnosis and management: work in progress. Minerva Anestesiol 2006;72:87-96.
5. Dellinger RP, Carlet J, Masur H, Gerlach H, Calandra T, Cohen J et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73.
6. HIH.org. Severe Sepsis Bundles. Available from http://wwwihiorg/IHI/ Topics/CriticalCare/Sepsis/Tools/SevereSepsisBundlehtm 2005:(last accessed 04/25/2006).
7. Hernandez G, Bruhn A, Romero C, Javier Larrondo F, De La Fuente R, Castillo L et al. Management of septic shock with a norepinephrine-based haemodynamic algorithm. Resuscitation 2005;66:63-9.
8. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United Stares: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10.
9. Vincent JL, Abraham E, Annane D, Bernard G, Rivers E, Van den Berghe G. Reducing mortality in sepsis: new directions. Critical Care 2002;6:S-S18.
10. Bernard GR., Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
11. Annane D, Sebille V, Charpentier C, Bollaert PE, François B, Korach JM et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-71.
12. Honore P, Jamez J-M, Wauthier M, Lee PA, Dugernier T, Pirenne B et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000;28: 3581-7.
13. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P. High-volume haemofiltration in human septic shock. Intensive Care Med 2001;27:978-86.
14. Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Janvier G. Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 2004;50:102-9.
15. ACCM/SCCM. Consensus conference definitions for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
16. Laterre P, Wittebole X. Clinical review: Drotrecogin alfa (activated) as adjunctive therapy for severe sepsis - practical aspects at the bedside and patient identification. Crit Care 2003;7:445-50.
17. Cornejo R, Downey P, Castro R, Romero C, Regueira T, Vega J et al. High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 2006;32:713-22.
18. Riker R, Picard J, Fraser G. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med 1999;27:1325-9.
19. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-67.
20. Knaus W, Draper E, Wagner D, Zimmerman J. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
21. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-10.
22. Shapiro NI, Howell MD, Talmor D, Lahey D, Ngo L, Buras J et al. Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med 2006;34:1025-32.
23. Kortgen A, Niederprüm P, Bauer M. Implementation of an evidence-based "standard operating procedure" and outcome in septic shock. Crit Care Med 2006;34:943-9.
24. Bellomo R, Goldsmith D, Uchino S, Buckmaster J, Hart GK, Opdam H et al. A prospective before-and-after trial of a medical emergency team. Med J Aust 2003;179:283-7.
25. Bellomo R, Goldsmith D, Uchino S, Buckmaster J, Hart GK, Opdam H et al. Prospective controlled trial of effect of medical emergency team on postoperative morbidity and mortality rates. Crit Care Med 2004;32:916-21.
26. Fiddian-Green RG. Associations between intramucosal acidosis in the gut and organ failure. Crit Care Med 1993;21:S103-S7.
27. Moran JL, O'Fathartaigh MS, Peisach AR, Chapman MJ, Leppard P. Epinephrine as an inotropic agent in septic shock: a dose-profile analysis. Crit Care Med 1993;21:70-7.
28. Annane D, Vignon P, Renault A, Bollaert PE, Charpentier C, Martin C et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 2007;370:676-84.
29. Grootendorst A, van Bommel E, van der Hoven B, van Leengoed L, van Osta A. High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992;18:235-40.
30. Hernandez G, Bruhn A, Romero C, Larrondo FJ, De La Fuente Cornejo R et al. Implementation of a norepinephrine-based protocol for management of septic shock: a pilot feasibility study. J Trauma 2006;60:77-81.
31. Herridge MS. Prognostication and intensive care unit outcome: the evolving role of scoring systems. Clin Chest Med 2003; 24:751-62.
32. Slade E, Tamber P, Vincent JL. The Surviving Sepsis Campaign: raising awareness to reduce mortality. Critical Care 2003;7:1-2.
33. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358:111-24.